- Home
- CELC vs BMRC Comparison
CELC vs BMRC Comparison
Compare CELC & BMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- BMRC
- Stock Information
- Founded
- CELC 2011
- BMRC 1989
- Country
- CELC United States
- BMRC United States
- Employees
- CELC N/A
- BMRC N/A
- Industry
- CELC Medical Specialities
- BMRC Major Banks
- Sector
- CELC Health Care
- BMRC Finance
- Exchange
- CELC Nasdaq
- BMRC Nasdaq
- Market Cap
- CELC 440.0M
- BMRC 365.9M
- IPO Year
- CELC 2017
- BMRC N/A
- Fundamental
- Price
- CELC $57.43
- BMRC $25.02
- Analyst Decision
- CELC Strong Buy
- BMRC Buy
- Analyst Count
- CELC 5
- BMRC 4
- Target Price
- CELC $53.60
- BMRC $26.25
- AVG Volume (30 Days)
- CELC 906.9K
- BMRC 81.3K
- Earning Date
- CELC 08-14-2025
- BMRC 10-27-2025
- Dividend Yield
- CELC N/A
- BMRC 4.04%
- EPS Growth
- CELC N/A
- BMRC N/A
- EPS
- CELC N/A
- BMRC 0.43
- Revenue
- CELC N/A
- BMRC $93,409,000.00
- Revenue This Year
- CELC N/A
- BMRC $59.17
- Revenue Next Year
- CELC N/A
- BMRC $15.96
- P/E Ratio
- CELC N/A
- BMRC $57.30
- Revenue Growth
- CELC N/A
- BMRC 59.35
- 52 Week Low
- CELC $7.58
- BMRC $19.11
- 52 Week High
- CELC $63.06
- BMRC $27.11
- Technical
- Relative Strength Index (RSI)
- CELC 64.38
- BMRC 62.38
- Support Level
- CELC $50.44
- BMRC $23.86
- Resistance Level
- CELC $63.06
- BMRC $25.45
- Average True Range (ATR)
- CELC 3.17
- BMRC 0.56
- MACD
- CELC -0.47
- BMRC 0.10
- Stochastic Oscillator
- CELC 60.71
- BMRC 83.14
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About BMRC Bank of Marin Bancorp
Bank of Marin Bancorp is a United States-based bank holding company. It conducts business through its wholly-owned subsidiary. The Bank provides a wide range of financial services to customers such as professionals, small and middle-market businesses, and individuals residing in Marin, Sonoma, Napa, San Francisco, Alameda, Contra Costa, San Mateo counties and others. The majority of its revenue comes from interest income.